D-0852-2022 Class II Terminated
FDA drug recall D-0852-2022 was initiated by Torrent Pharma Inc on Apr 11, 2022 and is designated Class II. Reason for recall: CGMP deviations: tablets cracking The recall status is terminated (terminated Jul 25, 2023). Affected quantity: 24,888 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- May 11, 2022
- Initiation Date
- Apr 11, 2022
- Termination Date
- Jul 25, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 24,888 bottles
Product description
Pantoprazole Sodium Delayed-Release Tablets, USP, 20 mg, Rx Only, 90 tablets per bottle, Manufactured by: Torrent Pharmaceuticals Ltd., Indrad-382 721, India, Manufactured for: Torrent Pharma Inc., Levittown, PA 19057, NDC# 13668-096-90.
Reason for recall
CGMP deviations: tablets cracking
Distribution pattern
Nationwide in the U.S.A
Code information
Lot #s: BA34G021, BA34G022, Exp. 09/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0852-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026